Evidence map›Paper›PMID 29948551›Full record

ArticleCellular and molecular neurobiology2018

Upregulation of miR-199a-5p Protects Spinal Cord Against Ischemia/Reperfusion-Induced Injury via Downregulation of ECE1 in Rat.

Ning Bao, Bo Fang, Huangwei Lv, Yanhua Jiang, Fengshou Chen, Zhilin Wang, Hong Ma

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ning BaoDepartment of Anesthesiology, First Affiliated Hospital, China Medical University, No. 155, North Nanjing Street, Heping District, Shenyang, Liaoning, People's Republic of China.
Bo FangDepartment of Anesthesiology, First Affiliated Hospital, China Medical University, No. 155, North Nanjing Street, Heping District, Shenyang, Liaoning, People's Republic of China.
Huangwei LvDepartment of Anesthesiology, First Affiliated Hospital, China Medical University, No. 155, North Nanjing Street, Heping District, Shenyang, Liaoning, People's Republic of China.
Yanhua JiangDepartment of Anesthesiology, First Affiliated Hospital, China Medical University, No. 155, North Nanjing Street, Heping District, Shenyang, Liaoning, People's Republic of China.
Fengshou ChenDepartment of Anesthesiology, First Affiliated Hospital, China Medical University, No. 155, North Nanjing Street, Heping District, Shenyang, Liaoning, People's Republic of China.
Zhilin WangDepartment of Anesthesiology, First Affiliated Hospital, China Medical University, No. 155, North Nanjing Street, Heping District, Shenyang, Liaoning, People's Republic of China.
Hong MaDepartment of Anesthesiology, First Affiliated Hospital, China Medical University, No. 155, North Nanjing Street, Heping District, Shenyang, Liaoning, People's Republic of China. mahong5466@yahoo.com.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia-reperfusion (I/R)-induced spinal cord injury can cause apoptotic damage and subsequently act as a blood-spinal cord barrier damage. MicroRNAs (miRNAs) contributed to the process of I/R injury by regulating their target mRNAs. miR-199a-5p is involved in brain and heart I/R injury; however, its function in the spinal cord is not yet completely clarified. In this study, we investigated the role of miR-199a-5p on spinal cord I/R via the endothelin-converting enzyme 1, especially the apoptosis pathway. In the current study, the rat spinal cord I/R injury model was established, and the Basso Beattie Bresnahan scoring, Evans blue staining, HE staining, and TUNEL assay were used to assess the I/R-induced spinal cord injury. The differentially expressed miRNAs were screened using microarray. miR-199a-5p was selected by unsupervised hierarchical clustering analysis. The dual-luciferase reporter assay was used for detecting the regulatory effects of miR-199a-5p on ECE1. In addition, neuron expression was detected by immunostaining assay, while the expressions of p-ERK, ERK, p-JNK, JNK, caspase-9, Bcl-2, and ECE1 were evaluated by Western blot. The results indicated the successful establishment of the I/R-induced spinal cord injury model; the I/R induced the damage to the lower limb motor. Furthermore, 18 differentially expressed miRNAs were detected in the I/R group compared to the sham group, and miR-199a-5p protected the rat spinal cord injury after I/R. Moreover, miR-199a-5p negatively regulated ECE1, and silencing the ECE1 gene also protected the rat spinal cord injury after I/R. miR-199a-5p or silencing of ECE1 also regulated the expressions of caspase-9, Bcl-2, p-JNK, p-ERK, and ECE1 in rat spinal cord injury after I/R. Therefore, we demonstrated that miR-199a-5p might protect the spinal cord against I/R-induced injury by negatively regulating the ECE1, which could aid in developing new therapeutic strategies for I/R-induced spinal cord injury.

Indexed as

Down-RegulationUp-RegulationAnimalsApoptosisDisease Models, AnimalEndothelin-Converting EnzymesMicroRNAsNeuronsRats, Sprague-DawleyReperfusion InjurySpinal CordSpinal Cord InjuriesTranscriptional ActivationEndothelin-Converting EnzymesMicroRNAsMIRN199 microRNA, ratApoptosisBlood–spinal cord barrierECE1Ischemia/reperfusionMiR-199a-5p

Identifiers

PMID29948551
PMCPMC11481941
OpenAlexW2808694933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.